Gara Jalqabaatti › Pheochromocytoma › Maryland
Qorannoo klinikaalii Pheochromocytoma Maryland keessatti
Qorannoo 10 Pheochromocytoma f Maryland keessatti hirmaatuu jiru.
Magaalota Maryland keessatti
Takkalaa qorannoo (Ingiliffa)
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06041516[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06479811Diagnosis of Pheochromocytoma
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 3 hanga 120 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT00004847Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Developmental Therapeutics ( Site 0108), Baltimore
- National Institutes of Health ( Site 0125), Bethesda
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04924075Project: Every Child for Younger Patients With Cancer
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- fi 1 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03206060Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT00001238Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT0642779818F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT06503146Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Johns Hopkins, Baltimore
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 14-Cam-2026 · NCT05636618Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.